120 related articles for article (PubMed ID: 30676334)
1. CRTC1-TRIM11 Fusion in a Case of Metastatic Clear Cell Sarcoma: Are CRTC1-TRIM11 Fusion-bearing Tumors Melanocytomas or Clear Cell Sarcomas?
Bontoux C; Baroudjian B; Le Maignan C; Vercellino L; Farges C; Guillemot D; Pierron G; Lebbé C; Battistella M
Am J Surg Pathol; 2019 Jun; 43(6):861-863. PubMed ID: 30676334
[No Abstract] [Full Text] [Related]
2. A case report of cutaneous melanocytoma with CRTC1-TRIM11 fusion: Is CMCT distinct from clear cell sarcoma of soft tissue?
Kashima J; Motoi T; Nishimaki M; Hayashi Y; Ogawa M; Kato I; Yamada R; Tonooka A; Horiguchi SI; Funata N; Hishima T; Yoshino K
Pathol Int; 2019 Aug; 69(8):496-501. PubMed ID: 31276279
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous Melanocytoma With CRTC1-TRIM11 Fusion: Report of 5 Cases Resembling Clear Cell Sarcoma.
Cellier L; Perron E; Pissaloux D; Karanian M; Haddad V; Alberti L; de la Fouchardière A
Am J Surg Pathol; 2018 Mar; 42(3):382-391. PubMed ID: 29240581
[TBL] [Abstract][Full Text] [Related]
4. CRTC1-TRIM11 fusion defined melanocytic tumors: A series of four cases.
Ko JS; Wang L; Billings SD; Pissaloux D; Tirode F; Berry R; De La Fouchardiere A
J Cutan Pathol; 2019 Nov; 46(11):810-818. PubMed ID: 31237704
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous Melanocytic Tumor With CRTC1::TRIM11 Translocation : An Emerging Entity Analyzed in a Series of 41 Cases.
Hanna J; Ko JS; Billings SD; Boivin F; Beaudoux O; Pissaloux D; Tirode F; Laga A; Fletcher CDM; de la Fouchardiere A
Am J Surg Pathol; 2022 Nov; 46(11):1457-1466. PubMed ID: 35993578
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report.
Vest BE; Harview CL; Liu V; Swick BL; Berrebi KG; Olivares S; Stone MS; Sargen MR; Gerami P
J Cutan Pathol; 2022 Dec; 49(12):1025-1030. PubMed ID: 35751643
[TBL] [Abstract][Full Text] [Related]
7. One step at a time: Melanocytic differentiation in fusion-driven cutaneous neoplasms.
Linos K
J Cutan Pathol; 2023 Dec; 50(12):1116-1118. PubMed ID: 37844955
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion: a case report.
Duan R; He X; Ma X; Huang F; Hu X
Diagn Pathol; 2024 Jan; 19(1):8. PubMed ID: 38184586
[TBL] [Abstract][Full Text] [Related]
9. MED15::ATF1-Rearranged Tumor: A Novel Cutaneous Tumor With Melanocytic Differentiation.
Ko JS; Lemahieu J; Billings SD; Tirode F; Payton D; Boone B; Pissaloux D; de la Fouchardiere A
Mod Pathol; 2024 Apr; 37(4):100438. PubMed ID: 38278485
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous melanocytic tumour with CRTC1::TRIM11 fusion in a case with recurrent local lymph node and distant pulmonary metastases at early stage: aggressive rather than indolent?
Yang L; Yin Z; Wei J; Chai J; Zhao D; Liu Y; Tang Y; Cheng H; Zhe W; Fan L
Histopathology; 2023 Jan; 82(2):368-371. PubMed ID: 36177516
[No Abstract] [Full Text] [Related]
11. CRTC1::TRIM11 cutaneous tumor: An update with local recurrence and lung metastasis in a pediatric patient.
Vest BE; Berrebi KG; Stone MS; Sargen MR; Gerami P
J Cutan Pathol; 2024 Mar; 51(3):181-183. PubMed ID: 37944913
[No Abstract] [Full Text] [Related]
12. TRIM11 binds to and destabilizes a key component of the activator-mediated cofactor complex (ARC105) through the ubiquitin-proteasome system.
Ishikawa H; Tachikawa H; Miura Y; Takahashi N
FEBS Lett; 2006 Sep; 580(20):4784-92. PubMed ID: 16904669
[TBL] [Abstract][Full Text] [Related]
13. Dermal melanocytic tumor with CRTC1-TRIM11 fusion: Report of two additional cases with review of the literature of an emerging entity.
Parra O; Bridge JA; Busam KJ; Shalin SC; Linos K
J Cutan Pathol; 2021 Jul; 48(7):915-924. PubMed ID: 33586183
[TBL] [Abstract][Full Text] [Related]
14. Expression of Tripartite Motif-Containing Proteactiin 11 (TRIM11) is Associated with the Progression of Human Prostate Cancer and is Downregulated by MicroRNA-5193.
Pan Y; Zhang R; Chen H; Chen W; Wu K; Lv J
Med Sci Monit; 2019 Jan; 25():98-106. PubMed ID: 30608062
[TBL] [Abstract][Full Text] [Related]
15. Emerging mesenchymal tumour types and biases in the era of ubiquitous sequencing.
Towery EA; Papke DJ
J Clin Pathol; 2023 Dec; 76(12):802-812. PubMed ID: 37550012
[TBL] [Abstract][Full Text] [Related]
16. An HIV-1 capsid binding protein TRIM11 accelerates viral uncoating.
Yuan T; Yao W; Tokunaga K; Yang R; Sun B
Retrovirology; 2016 Oct; 13(1):72. PubMed ID: 27737691
[TBL] [Abstract][Full Text] [Related]
17. TRIM11 Suppresses AIM2 Inflammasome by Degrading AIM2 via p62-Dependent Selective Autophagy.
Liu T; Tang Q; Liu K; Xie W; Liu X; Wang H; Wang RF; Cui J
Cell Rep; 2016 Aug; 16(7):1988-2002. PubMed ID: 27498865
[TBL] [Abstract][Full Text] [Related]
18. Tripartite motif‑containing 11 regulates the proliferation and apoptosis of breast cancer cells.
Dai X; Geng F; Li M; Liu M
Oncol Rep; 2019 Apr; 41(4):2567-2574. PubMed ID: 30816511
[TBL] [Abstract][Full Text] [Related]
19. TRIM11, a direct target of miR-24-3p, promotes cell proliferation and inhibits apoptosis in colon cancer.
Yin Y; Zhong J; Li SW; Li JZ; Zhou M; Chen Y; Sang Y; Liu L
Oncotarget; 2016 Dec; 7(52):86755-86765. PubMed ID: 27888625
[TBL] [Abstract][Full Text] [Related]
20. Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53.
Liu J; Rao J; Lou X; Zhai J; Ni Z; Wang X
Cell Physiol Biochem; 2017; 44(1):255-266. PubMed ID: 29190611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
